Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108586280B details a safer, 4-step synthesis for Posaconazole intermediates. Eliminate DIBAL-H risks and reduce manufacturing costs with this novel route.
Novel phenyl benzoxazole ruthenium catalyst enables mild oxidation of alkylpyridines. Reduces costs in pharmaceutical intermediate manufacturing with air as oxidant.
Patent CN113248442B reveals a cost-effective acetone-based route for ergothioneine intermediates, offering significant supply chain advantages for pharmaceutical manufacturers.
High-yield catalytic method for pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers.
Patent CN105622546B details a high-yield Vortioxetine synthesis avoiding toxic ferrocene reagents, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114634957B reveals enzymatic synthesis for 4AA. Offers cost reduction and supply chain reliability for API manufacturing partners.
Novel synthesis route for tetrafluorobenzyl-5-aminosalicylic acid salts avoiding dimer impurities. Enhanced stability and scalability for pharmaceutical manufacturing.
Patent CN110590886B details a novel 6'-nitrile LNA synthesis enhancing nuclease resistance. Discover scalable routes for high-affinity oligonucleotide intermediates.
Patent CN109265403A reveals imidazole hydrochloride catalysis for high-purity benzimidazole intermediates, offering cost reduction and scalable manufacturing solutions.
Patent CN106117289B reveals stable phosphorothioate nucleosides. Enhances siRNA stability and offers scalable synthesis for high-purity pharmaceutical intermediates globally.
Advanced synthesis of o-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenyl acetate offers high purity and streamlined manufacturing for reliable pharmaceutical intermediates supplier partnerships.
Discover a cost-effective synthesis of racemic clopidogrel via Pd-catalyzed C-H chlorination. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Discover advanced nickel-catalyzed synthesis for chiral alpha-amino boronic acids. Enhance supply chain reliability and reduce manufacturing costs for pharmaceutical intermediates.
Patent CN102040649A details a safe, cost-effective fluorination process for steroid intermediates using NFOBS/NFSI, offering significant supply chain advantages.
Novel KmAKR mutants enable high-yield enzymatic synthesis of rosuvastatin side chains, offering superior stability and cost-effective manufacturing solutions.
Novel methylation process for clarithromycin intermediates offers reagent recycling and reduced impurities for reliable pharmaceutical supply chains and cost efficiency.
Patent CN100347149C reveals a breakthrough solid catalyst method for valienamine production, offering high yields and streamlined purification for API manufacturers.
Patent CN114921507B reveals lipase resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one. High purity, green process, reliable supply chain for pharmaceutical intermediates.
Novel ion-exchange refining method for Rosuvastatin Calcium ensuring >99.5% purity and reduced heavy metals for pharmaceutical manufacturing.
Patent CN111825681A reveals a metal-free one-pot route for spiro compounds, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.